Mechanisms for the stimulation of pancreatic secretion have been investigated intensively but there is a paucity of information about the mechanisms of inhibition. This proposal examines the mechanism by which peptides from the intestine and pancreas suppressed exocrine secretion. Preliminary studies have shown that firstly, somatostatin inhibits pancreatic secretion in the intact animal and in the isolated, vascularly perfused rat pancreas but not in dispersed isolated acini; and secondly, tetrodotoxin, which blocks axonal transmission, abolishes this inhibitory action of somaostatin. These observations lead to the hypothesis that somatostatin does not act directly on the acinar cell, but rather influences neurones within the pancreas either to stimulate the release of a secondary inhibitor or to suppress the release of a stimulatory or permissive factor.
The specific aims of the proposal are, therefore, (1) to examine the direct and indirect effects of inhibitory peptides; (2) to determine the contribution of intrinsic neurones to the mechanism of inhibition; (3) to identify the chemical mediator of neuronal inhibition; and (4) to develop a method to isolate and explant intrinsic pancreatic neurons so as to study directly the release of neurotransmitters involved in the inhibitory process. The strategy is to study somatostatin as a representative inhibitor if all of the peptides act indirectly. If, however a direct acting peptide is found the possibility that it is common final mediator will be examined. The role of intrinsic pancreatic neurons will be studied in the isolated, perfused rat pancreas by using tetrodotoxin and by testing whether somatostatin inhibits the release of stimulatory neurotransmitters (acetylcholine, vasoactive intestinal polypeptide, gastrin releasing peptide and cholecystokinin) in the isolated perfused rat pancreas and in pancreatic slices. If pancreatic neurons can be successfully grown in culture, both the tissue expression and release of neurotransmitters will be studied directly using immunocytochemistry and radioimmunoassay, respectively. The knowledge gained about mechanism of inhibition will be applied in the prevention and treatment of pancreatitis and in the field of pancreatic transplantation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK040471-02
Application #
3240771
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1988-08-01
Project End
1991-07-31
Budget Start
1989-08-01
Budget End
1990-07-31
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
He, X; Nelson, M T; Debas, H T (1996) Intrapancreatic cholecystokinin mediates vagally stimulated exocrine secretion from the rat pancreas. Chin Med Sci J 11:32-5
Gray, J L; Bunnett, N W; Orloff, S L et al. (1994) A role for calcitonin gene-related peptide in protection against gastric ulceration. Ann Surg 219:58-64
Debas, H T; Nelson, M T; Bunnett, N W et al. (1992) Selective release of somatostatin by calcitonin gene-related peptide and influence on pancreatic secretion. Ann N Y Acad Sci 657:289-98
Bunnett, N W; Mulvihill, S J; Debas, H T (1991) Calcitonin gene-related peptide inhibits exocrine secretion from the rat pancreas by a neurally mediated mechanism. Exp Physiol 76:115-23
Mulvihill, S J; Bunnett, N W; Goto, Y et al. (1990) Somatostatin inhibits pancreatic exocrine secretion via a neural mechanism. Metabolism 39:143-8
Helton, W S; Mulholland, M M; Bunnett, N W et al. (1989) Inhibition of gastric and pancreatic secretion in dogs by CGRP: role of somatostatin. Am J Physiol 256:G715-20